Chinook Therapeutics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a KDNY research report →
Range $30 – $30
Price Chart
About the company
Chinook Therapeutics, Inc. , a biotechnology enterprise in the clinical development phase, is dedicated to the identification, progression, and market introduction of precise medical treatments for kidney-related conditions. The company's primary therapeutic candidate, atrasentan, is an endothelin receptor antagonist currently in Phase III clinical trials.
- CEO
- Eric L. Dobmeier
- IPO
- 2020
- Employees
- 214
- HQ
- Seattle, WA, US
Get TickerSpark's AI analysis on KDNY
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $2.71B
- P/E
- -14.07
- PEG
- 0.21
- P/S
- 441.93
- P/B
- 5.88
- EV/EBITDA
- -16.03
- Div Yield
- 0.00%
- Gross Margin
- 71.90%
- Op Margin
- -3020.28%
- Net Margin
- -3012.65%
- ROE
- -41.23%
- ROIC
- -35.04%
Latest fiscal year · YoY change
- Revenue
- $6.13M-88.1%
- Gross Profit
- $4.41M-91.2%
- Op Income
- $-185,083,000
- Net Income
- $-184,615,000-82.2%
- EPS
- $-2.87-29.3%
- OCF Growth
- -14.3%
- FCF Growth
- -13.9%
- 52W High
- $40.51
- 52W Low
- $18.34
- 50D MA
- $36.70
- 200D MA
- $26.37
- Beta
- 0.67
- RSI (14)
- 78
- Avg Volume
- 2.04M
No earnings-call transcripts are available for KDNY yet.
- Free Float
- 0.0%
- Shares Outstanding
- 67.05M
- Float Shares
- 0
of shares held by institutions
160 13F filers
Buy/sell ratio 0.01. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Tekla Capital Management LLC | 150.86K | ▲ 67.36K |
| Healthcor Management, L.P. | 60.00K | ▼ 206.83K |
| Pictet Asset Management SA | 22.83K | ▼ 1.15M |
| Gyon Technologies Capital Management, LP | 18.93K | ▲ 18.93K |
Held by 18 ETFs
Biggest fund positions in KDNY by dollar value.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 11, 23 | Thomas Dolca | sell | 13,300 |
| Aug 11, 23 | Thomas Dolca | sell | 23,522 |
| Aug 11, 23 | Thomas Dolca | sell | 5,948 |
| Aug 11, 23 | Thomas Dolca | sell | 13,300 |
| Aug 11, 23 | Oxtoby Andrew | sell | 160,000 |
| Aug 11, 23 | Oxtoby Andrew | sell | 40,000 |
| Aug 11, 23 | Krishnan Mahesh | sell | 4,401 |
| Aug 11, 23 | Krishnan Mahesh | sell | 26,600 |
| Aug 11, 23 | Krishnan Mahesh | sell | 1,275 |
| Aug 11, 23 | King Andrew James | sell | 60,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our KDNY coverage
Recent articles, reports, and earnings notes.
No research on KDNY yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate KDNY report →INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Chinook Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
accesswire.com · Aug 18
Novartis Completes Acquisition of Chinook Therapeutics
globenewswire.com · Aug 11
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Chinook Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
accesswire.com · Aug 5
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Chinook Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
accesswire.com · Aug 4
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Chinook Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
accesswire.com · Aug 3
Chief Scientific Officer Andrew King Sells 1,168 Shares of Chinook Therapeutics Inc (KDNY)
gurufocus.com · Aug 2
INVESTIGATION ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Chinook Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
accesswire.com · Aug 2
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Chinook Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
accesswire.com · Aug 1
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.